[1] EVANS P L, PRIOR J A, BELCHER J, et al. Obesity, hypertension and diuretic use as risk factors for incident gout: a systematic review and meta-analysis of cohort studies[J]. Arthritis Res Ther, 2018,20(1):136. [2] ABELES A M, PILLINGER M H. Gout and cardiovascular disease: crystallized confusion[J]. Curr Opin Rheumatol, 2019,31(2):118-124. [3] GU L, HUANG L, WU H, et al. Serum uric acid to creatinine ratio: A predictor of incident chronic kidney disease in type 2 diabetes mellitus patients with preserved kidney function[J]. Diab Vasc Dis Res, 2017,14(3):221-225. [4] CHUNLEI Y, LIUBAO G, TAO W, et al. The association between serum uric acid to creatinine ratio and renal disease progression in type 2 diabetic patients in Chinese communities[J]. J Diabetes Complications, 2019,33(7):473-476. [5] 王学东,吴永贵.安徽省成人肾病综合征分级诊疗指南(2016年版)[J].安徽医学,2017,38(5):523-536. [6] 陈霞,谷雪梅,方明.血清尿酸/肌酐比值对2型糖尿病早期肾损伤的预测价值[J].全科医学临床与教育,2018,16(3):320-322. [7] 孙悦,刘燕,王菲菲.血清尿酸/肌酐比值与早期糖尿病肾病的相关性探讨[J].中国卫生检验杂志,2021,31(13):1600-1602,1606. [8] KAWAMOTO R, NINOMIYA D, KIKUCHI A, et al. Serum uric acid to creatinine ratio is a useful predictor of renal dysfunction among diabetic persons[J]. Diabetes Metab Syndr, 2019,13(3):1851-1856. [9] 蒋俊兰,刘尚全. 血尿酸/肌酐比值与早期糖尿病肾脏病进展的关系[J].国际内分泌代谢杂志,2022,42(1):17-20,31. [10] WHITE W B, SAAG K G, BECKER M A, et al. Cardiovascular safety of febuxostat or allopurinol in patients with gout[J]. N Engl J Med, 2018,378(13):1200-1210. [11] 尹日平,范桢亮,杨梦凡,等.降尿酸治疗对慢性肾脏病1~4期患者肾功能影响的Meta分析[J].临床肾脏病杂志,2021,21(10):826-837. [12] 朱兵,李昂,刘宏伟,等.老年男性冠心病患者尿酸与肾功能的相关性分析[J].中华老年心脑血管病杂志,2021,23(12):1252-1255. [13] 章晓炎,盛虹,谢静远,等.高尿酸血症与老年慢性肾脏病患者肾功能的相关性研究[J].内科理论与实践,2020,15(3):161-166. [14] 刘丹丹,崔雯霞,冯艳伟,等.中老年血清尿酸水平与估算肾小球滤过率的相关性分析[J].解放军预防医学杂志,2019,37(5):137-138. [15] 张倩文.血尿酸或尿酸/肌酐水平在AECOPD患者中的临床意义[D].山东大学,2011. [16] 张昊.血尿酸与AECOPD患者相关性究的讨论[D].山西医科大学,2018. |